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Neuropeptides play pivotal roles in various biological events in the
nervous, neuroendocrine, and endocrine systems, and are corre-
lated with both physiological functions and unique behavioral
traits of animals. Elucidation of functional interaction between
neuropeptides and receptors is a crucial step for the verification of
their biological roles and evolutionary processes. However, most
receptors for novel peptides remain to be identified. Here, we
show the identification of multiple G protein-coupled receptors
(GPCRs) for species-specific neuropeptides of the vertebrate sister
group, Ciona intestinalis Type A, by combining machine learning
and experimental validation. We developed an original peptide
descriptor-incorporated support vector machine and used it to pre-
dict 22 neuropeptide–GPCR pairs. Of note, signaling assays of the
predicted pairs identified 1 homologous and 11 Ciona-specific neu-
ropeptide–GPCR pairs for a 41% hit rate: the respective GPCRs for
Ci-GALP, Ci-NTLP-2, Ci-LF-1, Ci-LF-2, Ci-LF-5, Ci-LF-6, Ci-LF-7, Ci-LF-8,
Ci-YFV-1, and Ci-YFV-3. Interestingly, molecular phylogenetic tree
analysis revealed that these receptors, excluding the Ci-GALP re-
ceptor, were evolutionarily unrelated to any other known peptide
GPCRs, confirming that these GPCRs constitute unprecedented
neuropeptide receptor clusters. Altogether, these results verified
the neuropeptide–GPCR pairs in the protochordate and evolutionary
lineages of neuropeptide GPCRs, and pave theway for investigating
the endogenous roles of novel neuropeptides in the closest relatives
of vertebrates and the evolutionary processes of neuropeptidergic
systems throughout chordates. In addition, the present study also
indicates the versatility of the machine-learning–assisted strategy for
the identification of novel peptide–receptor pairs in various organisms.
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G protein-coupled receptor
Ascidians (tunicates) are invertebrate chordates and thephylogenetically closest living relatives of vertebrates (1–3).
Such a critical phylogenetic position sheds light on the significance
of investigating the evolutionary process and diversity of biological
systems throughout the chordates, including the nervous, neuroen-
docrine, and endocrine systems (1, 4). Neuropeptides play various
pivotal roles in these systems as multifunctional signaling molecules,
and the majority of cognate receptors for neuropeptides belong to
the G protein-coupled receptor (GPCR) superfamily (5, 6). Thus,
the elucidation of specific neuropeptide–GPCR pairs is a primary
step in the investigation of the biological roles of neuropeptides,
their underlying regulatory mechanisms, and their evolutionary
history. In the cosmopolitan species of ascidians, Ciona intestinalis
Type A (Ciona robusta), many major neuropeptides (∼40) have
so far been characterized by purification, cDNA cloning, and
peptidomic approaches (7–13). These neuropeptides are classified
into two groups. The first group includes homologs or prototypes of
vertebrate neuropeptides: cholecystokinin, calcitonin, gonadotropin-
releasing hormones (GnRHs), galanin-like peptides (GALP),
tachykinin, and vasopressin (7–13). The molecular characterization
of Ciona neuropeptides substantiated that this invertebrate chordate
conserves a greater number of neuropeptide homologs than proto-
stomes (e.g., Caenorhabditis elegans and Drosophila melanogaster)
and other invertebrate deuterostomes (7–13), confirming the evo-
lutionary and phylogenetic relatedness of ascidians to vertebrates.
The second group includes Ciona-specific novel neuropeptides,
namely Ci-NTLPs, Ci-LFs, and Ci-YFV/Ls (SI Appendix, Fig.
S1 and Table S1), which share neither consensus motifs nor se-
quence similarity with any other peptides (8, 9). The presence of
both homologous and species-specific neuropeptides highlights this
phylogenetic relative of vertebrates as a prominent model organism
for studies of molecular and functional conservation and speciali-
zation in neuropeptidergic systems during chordate evolution. To
date, ∼160 GPCRs have been predicted and categorized into five
major groups (glutamate, rhodopsin, adhesion, frizzled, and secretin)
in Ciona (14). Furthermore, GPCRs for Ciona tachykinins (Ci-TKs)
(10), GnRHs (11), cholecystokinin (12), and vasopressin (13)
have been elucidated based on the similarity of their sequences to
vertebrate homologs. These findings are in good agreement with the
principle that GPCRs for homologous neuropeptides possess se-
quence similarity to homologous GPCRs conserved in other species.
In contrast, GPCRs for novel neuropeptides cannot be predicted
based on sequence similarity, which has hampered the identification
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of GPCRs for these neuropeptides. Indeed, no GPCRs for the
aforementioned novel neuropeptides (Ci-NTLPs, Ci-LFs, and Ci-
YFV/Ls) have ever been identified because these neuropeptides
share neither consensus motifs nor sequence similarity with any
other peptide. Thus, their cognate GPCRs cannot be predicted by
multiple-sequence alignment-based molecular phylogenetic analyses.
Similarly, although recent advances in transcriptomes and peptidomes
have led to the discovery of numerous putative highly conserved and
novel neuropeptides and their cognate receptor candidates (8, 15),
many novel GPCRs still remain to be deorphanized.
To date, reverse-pharmacology techniques have been employed
for the elucidation of novel ligand–GPCR pairs (16). However, the
reverse-pharmacology strategy for deorphanization of GPCRs is
analogous to gambling and not systematic: it is time-consuming,
costly, and serendipitous. Additionally, limited information re-
garding GPCR tertiary structures and variations in ligand-receptor
binding modes has hampered tertiary structure-based prediction or
virtual screening of peptide ligands for orphan GPCRs, including
homology modeling. Indeed, only a few low molecular-weight
molecules, but not peptides, have been characterized as novel li-
gands for GPCRs (17–20). These shortcomings indicate the need
for a new general and systematic approach for the identification of
various novel peptide–GPCR pairs.
Statistical machine learning has been used to predict various
ligand–receptor pairs (21–24). In the chemical genomics-based
strategy, known ligand–receptor pair information is encoded as
numerical vectors (descriptors) or kernels representing amino
acid sequences or physicochemical properties, which are input to
a machine-learning system, such as a support vector machine
(SVM). Indeed, machine-learning systems were used to predict
multiple novel ligand–protein pairs using integrated pattern
recognition of chemical properties and sequence information of
ligands and receptors (25). We previously predicted low
molecular-weight drug candidates for human GPCRs using this
machine learning system (21, 26). These findings demonstrate
the potential of machine learning in the prediction of Ciona
peptide–GPCR pairs. However, no peptide descriptors (PDs)
are available for machine learning for the reliable and efficient
prediction of neuropeptide–GPCR pairs (21, 26).
In this study, we identified 12 (11Ciona-specific and 1 homologous)
neuropeptide–GPCR pairs by a combination of an originally devel-
oped machine-learning system, PD-incorporated SVM, and experi-
mental evidence for specific signaling by the predicted neuropeptide–
GPCR pairs, and verified unprecedented phylogenetic relatedness of
GPCRs for neuropeptides.
Results
CPI Data Collection. A total of 1,352 compound–protein interac-
tions (CPIs) were collected from IUPHAR, GPCR-SARfari, and
UniProt annotations and literature and used as the training
dataset. These were composed of 531 human, 310 mouse,
379 vertebrate (vertebrates other than humans and mice), and
132 invertebrate (nonascidian invertebrates) CPIs (Dataset S1).
Subsequently, collected GPCRs or peptides were converted into
descriptors for machine learning (21, 26, 27). Molecular de-
scriptors for low molecular-weight compounds (28, 29) and
proteins (30, 31) have been available for machine-learning–
based prediction of CPIs (21, 26). However, chemical descrip-
tors are limited to low molecular-weight compounds due to the
computational burden imposed by larger compounds, and pro-
tein descriptors cannot be used with short amino acid peptides
due to the sparse information available for them for machine
learning. To develop PDs possessing peptide physicochemical
and biological properties, we initially designed PDs composed of
regular expressions (Fig. 1A and SI Appendix, Table S2), which
are 1- to 5-aa sequences comprising any amino acid and their
physicochemical properties defined by PROFEAT categories
(32). The PDs generated 25,935,478-dimensional bit (0, 1) vec-
tors, which represent the absence and presence of subsequences
matching the regular expressions. GPCRs were encoded with a
Fig. 1. Overview of PD-incorporated SVM. (A) Regular expression-based PDs were generated by concatenating five elements, which represent amino acid
categories, and regular expressions for these fragments were calculated. Ambiguous residue categories for regular expressions are listed in SI Appendix, Table
S2. (B) Conventional prediction methods include computation of kernels, which are necessary for SVM to learn and predict interaction pairs, from all of the
elements of a GPCR and ligand descriptors. In contrast, the proposed method includes a step for GAFS. In GAFS, descriptor sets were selected to improve the
prediction performance with the AUC, which was measured by LOSO cross-validation.
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transmembrane (TM) z-scale descriptor according to our pre-
vious study (21).
Subsequently, we estimated the distribution of similarity
scores (SSs) between each peptide or GPCR and the samples
most similar to themselves or other subsets, as previously de-
scribed (21). Tanimoto coefficients (33) of TM z-scale descrip-
tors and the aforementioned original PDs were used for the
estimation of the SSs of the GPCRs and peptides, respectively.
The average GPCR SSs of humans, mice, vertebrates, and in-
vertebrates with themselves were 0.849 ± 0.020, 0.860 ± 0.020,
0.905 ± 0.016, and 0.762 ± 0.026, respectively (Fig. 2A and SI
Appendix, Fig. S2A). The average GPCR SSs of humans, mice,
vertebrates, and invertebrates with other subsets were 0.855 ±
0.015, 0.906 ± 0.012, 0.912 ± 0.012, and 0.436 ± 0.014, re-
spectively (Fig. 2B and SI Appendix, Fig. S2B). Although GPCR
SSs of humans, mice, and vertebrates were all higher than 0.8,
the SSs of invertebrates were less, at 0.436, indicating the dis-
similarity of our collected invertebrate GPCRs. The average
peptide SSs of humans, mice, vertebrates, and invertebrates with
themselves were 0.800 ± 0.025, 0.751 ± 0.029, 0.823 ± 0.024, and
0.314 ± 0.031, respectively (Fig. 2C and SI Appendix, Fig. S2C).
The average peptide SSs of humans, mice, vertebrates, and in-
vertebrates with other subsets were 0.676 ± 0.029, 0.778 ± 0.027,
0.822 ± 0.021, and 0.268 ± 0.017, respectively (Fig. 2D and SI
Appendix, Fig. S2D). Similar to GPCR SSs, the invertebrate
peptide SS (0.268) was extremely small compared with the SSs of
humans, mice, and vertebrates (>0.6). This invertebrate-specific
distribution of SSs (Fig. 2 and SI Appendix, Fig. S2) represents
the sequence varieties of invertebrate GPCRs and peptides, but
vertebrate GPCRs and peptides contain more orthologs than
those in other species. To estimate prediction performance of
species-specific CPIs, we evaluated the performance using leave-
one-species-out (LOSO) validation (21, 26, 28).
PD-Incorporated SVM Prediction of Ciona Neuropeptide–Receptor
Pairs. PDs encoding peptides and a TM z-scale descriptor
encoding GPCRs (Fig. 1B) were utilized for the encoding of
1,352 CPIs (Dataset S1) and the same number of generated
noninteraction pairs (Materials and Methods). The resulting CPIs
and noninteraction pairs were in turn utilized as training sets for
SVMs (Fig. 1B). The prediction performances of trained SVMs
were evaluated by LOSO internal validation using the predicted
CPIs and noninteraction pairs as test sets (21, 26, 28). Because
the CPI datasets partitioned into respective subsets for peptide–
GPCR interactions in humans, mice, other vertebrates, and in-
vertebrates were predicted using models containing the other
datasets in a LOSO analysis, species-wide prediction perfor-
mance was evaluated by LOSO cross-validation. The LOSO
analysis using the PD-incorporated SVM produced values for
leave-humans-, mice-, vertebrates-, and invertebrates-out of
0.949 ± 0.003, 0.977 ± 0.001, 0.988 ± 0.001, and 0.592 ± 0.032 for
the area under the receiver operating characteristic curve (AUC)
and 0.884 ± 0.010, 0.937 ± 0.010, 0.971 ± 0.003, and 0.501 ±
0.101 for accuracy (ACC) (Fig. 3A and SI Appendix, Table S3).
To confirm the prediction performance of the present PDs,
the peptide–receptor prediction performance using other de-
scriptors—specifically, 5–0, 5–1, and 5–2 mismatch descriptors
(30, 34), a class of string kernels that compare sequence strings
representing k-mer subsequences—were also evaluated by
LOSO. LOSO analysis using the 5–0 mismatch descriptors for
leave-humans-, mice-, vertebrates-, and invertebrates-out yielded
0.800 ± 0.011, 0.875 ± 0.003, 0.921 ± 0.012, and 0.436 ± 0.006 for
the AUC and 0.743 ± 0.031, 0.852 ± 0.005, 0.861 ± 0.037, and
0.443 ± 0.020 for ACC (SI Appendix, Fig. S4A and Table S3).
LOSO analysis using the 5–1 mismatch descriptors for leave-
humans-, mice-, vertebrates-, and invertebrates-out yielded
0.867 ± 0.011, 0.925 ± 0.004, 0.962 ± 0.003, and 0.473 ± 0.012 for
the AUC and 0.820 ± 0.021, 0.890 ± 0.012, 0.924 ± 0.017, and
0.496 ± 0.022 for ACC (SI Appendix, Fig. S4A and Table S3).
LOSO analysis using the 5–2 mismatch descriptors for leave-
humans-, mice-, vertebrates-, and invertebrates-out yielded
0.792 ± 0.008, 0.848 ± 0.011, 0.898 ± 0.009, and 0.497 ± 0.010 for
the AUC and 0.737 ± 0.031, 0.815 ± 0.018, 0.861 ± 0.024, and
0.493 ± 0.020 for ACC (SI Appendix, Fig. S4A and Table S3).
These data indicate that the scores of our developed PDs were
higher than those of 5–0, 5–1, and 5–2 mismatch descriptors,
Fig. 2. Boxplots of SSs for GPCRs and peptides. (A) SSs for GPCRs against
other GPCRs in the same subsets (humans, mice, other vertebrates, and
nonascidian invertebrates), (B) SSs for GPCRs against other GPCRs in other
subsets, (C) SSs for peptides against other peptides in the same subsets, and
(D) SSs for peptides against other peptides in other subsets. *P < 0.05.
Fig. 3. The original PD-incorporated SVM showed sufficient prediction
performance for neuropeptide–GPCR pairs of various species. (A) AUCs of
model composed from original PDs and the resultant model from the
second-round GAFS are shown with error bars representing the SEM of
five repeated experiments with independently generated negative data.
*P < 0.05. (B and C ) Prediction results for C. intestinalis CPIs using (B) the
model resulting from original PDs and (C) the model resulting from the
second-round GAFS are shown as a heat map. The color gradient represents
predicted values for individual peptide–GPCR interactions. The known pairs
are outlined in yellow.
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confirming high prediction performance of the developed PDs.
Consequently, we employed our PDs for the following analysis.
However, the prediction performance for leave-invertebrates-out
was still lower (0.592 ± 0.032 for the AUC) than that for ver-
tebrates (leave-humans-, mice-, and vertebrates-out). To im-
prove the prediction performance, we optimized the PDs using
two rounds of genetic algorithm-based feature selection (GAFS)
(Fig. 1B; also see SI Appendix, Supplemental Methods).
After GAFS, the optimized PDs displayed leave-humans-,
mice-, and vertebrates-out of 0.955 ± 0.002, 0.972 ± 0.004, and
0.986 ± 0.002 for the AUC and 0.889 ± 0.011, 0.926 ± 0.013, and
0.959 ± 0.006 for ACC. Furthermore, the AUCs and ACCs for
leave-invertebrates-out improved to 0.813 ± 0.006 and 0.847 ±
0.076, respectively. These scores confirmed high prediction
performance of the neuropeptide–GPCR pairs for any species by
the PD-incorporated SVM. Subsequently, we examined the
prediction accuracy of the PD-incorporated SVM, trained with
all 1,352 CPIs (Dataset S1) and the noninteraction pairs, for
eight known CPIs for Ciona peptide and their cognate receptor
pairs (Dataset S1) that were not included in the LOSO analysis.
As shown in Fig. 3C, Ci-TK-I, Ci-TK-II, and cionin (Ciona
cholecystokinin homolog) were predicted to interact specifically
with cognate receptors Ci-TK-R, CioR1, and CioR2, respec-
tively, by machine learning (Fig. 3C). These outputs were com-
pletely consistent with the previous experimental evidence for
their specific interactions (10, 12). Similarly, t-GnRH-3, t-GnRH-5,
and t-GnRH-6 were predicted to interact with their cognate re-
ceptors with somewhat low ligand selectivity, as previously
reported (11). Thus, the present PD-incorporated SVM was
found to predict all eight known Ciona peptide–GPCR pairs
with an accuracy of 80.95%. In contrast, no positive Ciona
peptide–GPCR pairs were predicted with machine-learning
models with 5–0, 5–1, and 5–2 mismatch descriptors (30, 34),
which agrees with low leave-invertebrates-out validation (Fig.
3B and SI Appendix, Fig. S4 B–E). Collectively, the LOSO
evaluation (Fig. 3A) and prediction accuracy for datasets of
Ciona neuropeptide–receptor pairs (Fig. 3C) demonstrate that
the PD-incorporated SVM model detects neuropeptide–
GPCR pairs in both vertebrates and invertebrates. To the best
of our knowledge, this is unique as a machine-learning model
that can predict peptide-GPCR pairs of any animal species
with high accuracy.
Using the PD-incorporated SVM trained with all 1,352 CPIs
(rows 2–1,353 in Dataset S1) and the noninteraction pairs, we
predicted the interactions between 19 Ciona neuropeptides (SI
Appendix, Fig. S1 and Table S1) identified by our previous
peptidomics study of the central nervous system (8) and 140 pu-
tative Ciona GPCRs (Dataset S2) extracted from the Ghost
database (35) by GPCRalign (36). Each GPCR ID was abbre-
viated by omitting the splicing variant information (SI Appendix,
Table S4). The prediction values for each pair ranged from 1
(absolute interaction) to 0 (absolute noninteraction). PD-
incorporated SVM analysis of a total of 2,660 Ciona peptide–
GPCR pairs [19 Ciona peptides (SI Appendix, Table S1) × 140
Ciona GPCRs (Dataset S2)] were subjected to PD-incorporated
SVM prediction and a total of 13 putative peptide–GPCR pairs
were produced with prediction scores higher than 0.7 for Ciona
galanin-like peptide (Ci-GALP), Ci-NTLP-2, Ci-NTLP-3, Ci-LF-
2, Ci-LF-3, Ci-LF-8, Ci-YFV-1, and Ci-YFV-3 (Fig. 4A and SI
Appendix, Table S5).
Identification of 12 Neuropeptide–GPCR Pairs by Experimental
Validation of the Predicted Pairs. We predicted and evaluated
neuropeptide-GPCR pairs in two stages using a self-training
strategy for semisupervised learning (37). For the first-stage
evaluation, we experimentally assessed seven pairs (Ci-GALP-
KH.C3.660; Ci-NTLP-2-KH.C9.683 and KH.C3.920; Ci-LF-2-
KH.C2.127, KH.L172.28, and KH.C2.1132; and Ci-YFV-1-KH.
C1.745) that had high prediction values (SI Appendix, Table S5)
in the aforementioned model. Each promiscuous Gαq16-fused
GPCR was transiently expressed in Sf9 cells, and intracellular
Ca2+ mobilization was assessed in the presence of various con-
centrations of the peptide ligands. The cell-based signaling assay
demonstrated that Ci-GALP, Ci-NTLP-2, Ci-LF-2, and Ci-YFV-
1 induced Ca2+ mobilization in cells transfected with KH.C3.660
(Fig. 4B), KH.C9.683 (Fig. 4C), KH.C2.1132 (Fig. 4D), and KH.
C1.745 (Fig. 4E), respectively, with nanomolar efficacy (Table 1).
In contrast, dose-dependent responses were not observed with cells
expressing other receptors. Furthermore, the PD-incorporated
SVM was provided with data for the four experimentally vali-
dated Ciona GPCR–neuropeptide pairs as positive examples and
three other pairs as negative examples for the second-stage vali-
dation, using a self-training strategy for semisupervised learning
(37). The feature set for training and prediction was not changed
from the PD-incorporated feature set used above, and the addi-
tional datasets were expected to update the discriminant functions
(weight vectors) for the possible estimation of peptide–receptor
interactions, leading to the prediction of more peptide–receptor
pairs. As shown in Fig. 5A, the updated PD-incorporated SVM with
additional training data output 22 putative peptide–GPCR pairs for
Ci-NTLP-4, Ci-LF-1, Ci-LF-2, Ci-LF-5 to -8, Ci-YFV-1 to -3, and
Ci-YFL-1 (SI Appendix, Table S6). Ca2+-mobilization assays also
verified specific (nanomolar efficacy) interactions of KH.C4.122
with Ci-LF-1 and Ci-LF-6 (Fig. 5 B and C); of KH.C2.1037 with Ci-
LF-1, Ci-LF-5, and Ci-LF-6 (Fig. 5 D–F); of KH.C2.878 with
Ci-LF-7 (Fig. 5G); of KH.C2.212 with Ci-LF-8 (Fig. 5H); and
of KH.C8.781 with Ci-YFV-3 (Fig. 5I and Table 1). In contrast,
Fig. 4. GPCRs for Ci-GALP, Ci-LF-2, Ci-NTLP-2, and Ci-YFV-1 were identified
by signaling assays based on the prediction by PD-incorporated SVM. (A)
Prediction results for C. intestinalis CPIs are shown as a heat map. The color
gradient represents the predicted value for each interaction between pep-
tide and GPCR. Only GPCRs that were predicted to interact with at least one
peptide with prediction scores higher than 0.7 are shown. Dose-dependent
responses of (B) Ci-GALP, (C) Ci-NTLP-2, (D) Ci-LF-2, and (E) Ci-YFV-1 in Sf-
9 cells expressing each receptor were assessed with intracellular Ca2+ mo-
bilization, and sigmoid curves were calculated using Prism 3.03. Error bars
represent the SEM of more than three experiments.
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all of the above neuropeptides show no Ca2+ mobilization at other
GPCRs with prediction scores higher than 0.7. Altogether, these
results provided evidence for the identification of a Ci-GALP re-
ceptor (Ci-GALP-R), Ci-NTLP-2 receptor (Ci-NTLP-2-R), Ci-LF-
1 receptor (Ci-LF-1-R), Ci-LF-2 receptor (Ci-LF-2-R), Ci-LF-5/
6 receptor (Ci-LF-5/6-R), Ci-LF-7 receptor (Ci-LF-7-R), Ci-LF-
8 receptor (Ci-LF-8-R), Ci-YFV-1 receptor (Ci-YFV-1-R), and Ci-
YFV-3 receptor (Ci-YFV-3-R) (Table 1). Although Ci-LF-1-R and
Ci-LF-5/6-R were weakly activated by Ci-LF-6 and Ci-LF-1 (Table
1), respectively, Ci-LF-1-R exhibited a 42-fold selectivity for Ci-LF-
1 relative to Ci-LF-6, while Ci-LF-5/6 exhibited a 91-fold selectivity
for Ci-LF-6 relative to Ci-LF-1. Consequently, Ca2+-mobilization
assays for a total of 29 predicted pairs (7 pairs from the first-stage
evaluation and 22 from the second-stage evaluation) resulted in a
41% hit rate (12 experimentally validated pairs).
Molecular Phylogenetic Tree Analysis of Identified Ciona Neuropeptide
GPCRs. To evaluate the presence of known receptors closely related
to the identified Ciona GPCRs, gene trees were estimated by col-
lecting similar bilaterian sequences (Fig. 6). We used the Ci-GALP-
R sequence as a query with the Basic Local Alignment Search Tool
(BLAST) to demonstrate that similar sequences were detected in
genome data representing all deuterostome lineages. Among them,
Ci-GALP-R displayed 37–42% sequence identity (SI Appendix, Fig.
S5A) to eight vertebrate galanin or GALP receptors (38) and 35–
44% sequence identity (SI Appendix, Fig. S5A) to nine putative
cephalochordate galanin or GALP receptors, indicating sequence
identity of Ci-GALP-R to those of other galanin/GALP receptor
family GPCRs. Molecular phylogenetic tree analysis demonstrated
that urochordate GALP-Rs were positioned outside of either ver-
tebrates or cephalochordate galanin/GALP receptors (SI Appendix,
Fig. S5A), indicating that urochordate GALP-Rs evolved in unique
ways. However, the deuterostome GALP-R clade including Ci-
GALP-R was consistently supported by both neighbor-joining
(NJ) and maximum-likelihood (ML) analysis (Fig. 6A and SI Ap-
pendix, Fig. S5 A, 1–3), revealing that Ci-GALP-R shares a com-
mon ancestor with the vertebrate galanin receptor proteins.
A BLAST search using the Ci-NTLP-2-R sequence as a query
identified similar deuterostome sequences, including eight ver-
tebrate adhesion GPCRs (20–24% identity) (SI Appendix, Fig.
S5B). However, among these BLAST hits, phylogenetic analyses
did not identify any nonurochordate sequence similar to the Ci-
NTLP-2-R sequence (Fig. 6B and SI Appendix, Fig. S5B). In
addition, the sequence alignment showed that the N terminus of
Ci-NTLP-2-R is shorter than that of other GPCRs (SI Appendix,
Fig. S5 B, 4). Some adhesion GPCRs are known as receptors for
high molecular-weight protein ligands, such as collagen (adhe-
sion GPCR G6; ENST00000394143.5) (39, 40) and neurexins
(adhesion GPCR L1; ENST00000340736.10) (41). Notably, the
amino acid length of the ligand of Ci-NTLP-2-R, Ci-NTLP-2
(8 aa, MMLGPGIL) (SI Appendix, Table S1), is far shorter
than those of collagens (>1,000 aa) and FLRT3 (>600 aa). Given
that a significant sequence identity was not found between Ci-
NTLP-2 and these proteins, Ci-NTLP-2-R is considered to be a
GPCR for a short neuropeptide but not an adhesion-related protein.
A BLAST search using the Ci-LF-1-R sequence as a query
identified similar deuterostome sequences (SI Appendix, Fig.
S5C). Ci-LF-Rs showed 21–26% sequence identity to 10 verte-
brate GPCRs, including class A small molecular-weight trans-
mitters GPCRs (cannabinoid receptors, adenosine receptors,
and adrenergic receptors) (SI Appendix, Fig. S5C). Phylogenetic
analyses indicated that all Ci-LF-Rs belong to the Ciona-specific
clade (Fig. 6C) and this clade is deeply nested within the uro-
chordate LF-R clade consisting of presumable LF-R sequences
of Botryllus schlosseri and Oikopleura dioica. The urochordate
LF-R clade, however, did not have any closely related sequence
of nonurochordate deuterostomes (SI Appendix, Fig. S5C). This
result suggests that, after a split of other tunicate lineages, the
Ci-LF-Rs evolved within the Ciona lineage as paralogs via gene
multiplication and are in good agreement with the finding that
the Ci-LF-Rs share little sequence homology with any hitherto
known GPCR for peptides.
A BLAST search using the Ci-YFV-1-R sequence as a query
identified similar sequences from urochordates but not from
other deuterostomes (Fig. 6D). Phylogenetic analyses (SI Ap-
pendix, Fig. S5D) demonstrated that Ci-YFV-Rs were grouped
with sequences of probable YFV-Rs of Ciona and B. schlosseri.
This result suggests that Ci-YFV-Rs were generated within the
urochordate lineage. Combined with the experimental evidence
for specific neuropeptide–GPCR pairs (Figs. 4 and 5), these
molecular phylogenetic tree analyses suggest that Ci-NTLP-Rs,
Ci-LF-Rs, and Ci-YFV-Rs are not closely related to any other
known GPCRs.
Expression of Ci-GALP-R, Ci-NTLP-2-R, Ci-LF-R, and Ci-YFV-R Genes in
Various Tissues. Real-time PCR revealed the expression patterns
of the identified GPCRs. For example, Ci-LF-Rs, except Ci-LF-
8-R, were shown to be expressed specifically in the oral and atrial
siphons (Fig. 7), suggesting some biological roles of Ci-LF-1 to
-7 in feeding behavior. Ci-GALP-R, Ci-YFV-1-R, and Ci-YFV-3-
R were more highly expressed in the neural complex, compared
with other identified GPCRs (Fig. 7). These results demonstrate
the unique expression profile of these GPCRs and suggested that
their peptide ligands produce diverse biological functions.
Discussion
Neuropeptides play multiple biological roles upon binding to
their cognate receptors expressed in various tissues and cells.
Thus, identification of neuropeptide–GPCR pairs, namely,
deorphanization of GPCRs, is a crucial step in the elucidation of
their endogenous roles. Moreover, both novel and homologous
neuropeptides have been characterized in various organisms,
highlighting the significance of neuropeptidergic signaling sys-
tems in molecular and functional evolution and diversification
in the animal kingdom. However, elucidation of nonhomologous
neuropeptide–receptor pairs remains a severe bottleneck in a
wide range of biological sciences, because prediction and identi-
fication of the receptors for novel peptides is one of the most time-
consuming and serendipity-dependent tasks in biology due to low
sequence similarities and poor molecular phylogenetic correlations,
even in human and model organisms. Although reverse-pharmacological
strategies generally require multiyear trial-and-error testing to
elucidate one ligand-receptor pair, the identification of receptors
for novel ligands, including species-specific nonhomologous pep-
tides, still depends on this strategy (42). A large-scale combina-
torial reverse-pharmacological method identified 19 invertebrate
neuropeptide GPCRs (16), but this strategy requires multistep
experiments for numerous peptide–receptor pair candidates, and
most of the identified peptide–receptors were homologs of other
species. In this study, we efficiently and systematically identified
multiple neuropeptide–GPCR pairs of the phylogenetically closest
relative of vertebrates,C. intestinalis Type A, with the assistance of an
original machine learning-based approach. Of particular significance
Table 1. Identified GPCR–peptide pairs
Ghostdatabase ID
for receptor gene Receptor gene name Ligand EC50 (nM)
KH.C3.660 Ci-GALP-R Ci-GALP 1.29
KH.C9.683 Ci-NTLP-2-R Ci-NTLP-2 11.05
KH.C4.122 Ci-LF-1-R Ci-LF-1 5.25
KH.C4.122 Ci-LF-1-R Ci-LF-6 223.87
KH.C2.1037 Ci-LF-5/6-R Ci-LF-1 141.25
KH.C2.1037 Ci-LF-5/6-R Ci-LF-5 4.78
KH.C2.1037 Ci-LF-5/6-R Ci-LF-6 1.55
KH.C2.1132 Ci-LF-2-R Ci-LF-2 0.71
KH.C2.878 Ci-LF-7-R Ci-LF-7 2.04
KH.C2.212 Ci-LF-8-R Ci-LF-8 1.35
KH.C1.745 Ci-YFV-1-R Ci-YFV-1 24.55
KH.C8.781 Ci-YFV-3-R Ci-YFV-3 1.98
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is that we succeeded in elucidating 1 homologous and 11 Ciona-
specific neuropeptide–GPCR pairs during validation of 29 predicted
peptide–receptor pairs. This represents a 41% hit rate using only
1,352 CPIs, namely, data for known endogenous peptide–GPCR
pairs. Examination of these 29 predicted interactions and eluci-
dation of 12 (11 Ciona-specific and 1 homologous) neuropeptide–
GPCR pairs were completed within only 9 mo after the first-round
prediction of Ciona neuropeptide–GPCR pairs (Fig. 4A). This is an
obviously higher throughput than that of reverse-pharmacological
strategies. Consequently, the present study illustrates the ef-
fectiveness of combining PD-incorporated SVM with cell-based
experimental validation for the identification of neuropeptide–
GPCR pairs.
Combined with previously identified homologous neuropep-
tide–GPCR pairs, this study led to the elucidation of a total of
26 neuropeptide–GPCR pairs in Ciona, which is comparable to
those of conventional protostomian model organisms, such as
Drosophila and C. elegans (5). Previously, only a few biological
roles of Ciona neuropeptides had been elucidated: regulation of
vitellogenic follicles by Ci-TK (9, 43) and metamorphosis by
GnRH (9, 44). Thus, the present identification of multiple
neuropeptide–GPCR pairs (Figs. 5 and 6) and localization of
the GPCR gene expression surely facilitates the elucidation of
neuropeptidergic molecular mechanisms (Fig. 7) and networks
underlying various biological events regulated by the nervous,
neuroendocrine, and endocrine systems in Ciona. Furthermore,
because Ciona is the closest living relative of vertebrates, this
study is also expected to contribute a great deal to the
exploration of the common and species-specific evolution of
the nervous, neuroendocrine, and endocrine systems throughout
the Chordata phylum.
We verified that Ci-LF-1, -2, -5, -6, -7, and -8 and Ci-YFV-
1 and -3 exhibited prominent selectivity to their receptors (Figs. 3
and 4), whereas receptors for Ci-LF-3 and -4, Ci-YFV-2, and Ci-
YFL-1 have yet to be elucidated. This is mainly due to the failure
of expression of the most probable receptor candidate proteins
in expression systems, including mammalian cells, insect cells,
and Xenopus oocytes, rather than implicit prediction of peptide–
receptor systems. Replacement of the N-terminal regions of
Ciona GPCRs with those of mammals or insects should result in
functional expression, leading to the experimental validation of
predicted peptide–GPCR pairs.
Recently, molecular phylogenetic approaches have provided
some insight into evolutionary aspects and classification of in-
vertebrate peptides, GPCRs, and peptide–GPCR pairs (5, 45).
For example, integrative molecular phylogenetic analyses iden-
tified 29 categories of peptide and GPCR subfamilies based on
position-specific scoring matrices of GPCRs and peptide pre-
cursors, followed by prediction of peptide–GPCR pairs (5, 45).
However, these methods were limited to the prediction of known
homologous peptide–GPCR pairs. Of particular significance is
that Ci-NTLP-2-R, Ci-LF-Rs, and Ci-YFV-Rs constitute unique
clades with orphan GPCRs or GPCRs for nonpeptide endoge-
nous ligands, not with hitherto known GPCRs for peptides,
indicating that these genes were generated in a species-specific
lineage (Fig. 6 and SI Appendix, Fig. S5). The existence of such
Ciona-specific evolutionarily unrelated neuropeptide GPCR
genes is compatible with a rapid evolutionary rate of the Ciona
genome and species-specific gene multiplication (46). In other
words, the present molecular phylogenetic trees (Fig. 6 and SI
Appendix, Fig. S5) strongly suggest that novel neuropeptide
GPCRs also constitute unique clades with GPCRs for non-
peptidic ligands in other species, including humans, supporting
the view that methods based on sequence similarity or molecular
phylogenetic relatedness have not been useful for predicting
novel peptide–GPCR pairs. In contrast, unprecedented mo-
lecular mechanisms and evolutionary processes of peptide–
GPCR interactions have a high likelihood of being recognized
by the PD-incorporated SVM, suggesting that the present
machine-learning approach will lead to the exploration of new
Fig. 5. Data feedback of experimentally validated results of four Ciona
neuropeptide–GPCR pairs, leading to the identification of eight additional
pairs. (A) Prediction results for C. intestinalis CPIs are shown as a heat map.
The color gradient represents the predicted value for each interaction be-
tween peptide and GPCR. Only GPCRs that were predicted to interact with at
least one peptide with prediction scores higher than 0.7 are shown. Dose-
dependent responses of (B and D) Ci-LF-1, (E) Ci-LF-5, (C and F) Ci-LF-6, (G) Ci-
LF-7, (H) Ci-LF-8, and (I) Ci-YFV-3 in Sf-9 cells expressing each receptor were
assessed with intracellular Ca2+ mobilization, and sigmoid curves were cal-
culated using Prism 3.03. Error bars represent the SEM of more than three
experiments.
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phylogenetically unrelated GPCR repertoires in a wide range of
species, including humans.
Machine-learning methods have provided predictive models
or simulations of ligand–receptor interactions (24, 47–50).
However, the experimental evidence for these has been limited
to nonendogenous small compounds (26). Moreover, to the best
of our knowledge, this prediction of peptide–receptor pairs using
machine learning enabled by the development of original PDs is
unique (Fig. 1 and SI Appendix, Table S2). Collectively, the
present study shows identification of cognate endogenous pep-
tide–receptor pairs using a sequential combination of machine
learning and experimental validation. Additionally, the afore-
mentioned hit rate of the PD-incorporated SVM (41%) was
much higher than those for the elucidation of GPCRs for small
nonendogenous compound prediction using in silico virtual
screening, such as structure-based (20) and other chemical ge-
nomic models (26).
The LOSO validation, which enabled the evaluation of
species-wide prediction performance, contributed to estimating
the prediction performance of the species-specific CPIs. We also
estimated the prediction performances using fivefold cross-
validation (5-CV) (24, 26). As shown in SI Appendix, Fig. S6,
5-CV showed prediction performance of AUCs higher than
0.85 for all descriptors, including 5–0, 5–1, and 5–2 mismatch
descriptors and PDs, whereas no known Ciona peptide–GPCR
pairs were predicted (SI Appendix, Fig. S4 B–D). In contrast,
despite low performance of the original SVM with any descrip-
tors validated by leave-invertebrates-out analysis (AUC < 0.6),
GAFS-optimized PD-incorporated SVM validated by leave-
invertebrates-out analysis showed higher prediction perfor-
mance (AUC of 0.813) and, indeed, output complete prediction
of all known Ciona peptide–GPCR pairs (Fig. 3 B and C) and led
to the elucidation of 12 Ciona peptide–GPCR pairs (Figs. 4 and
5). Collectively, these results proved that 5-CV overestimated the
prediction performance compared with leave-invertebrates-out
analysis. These gaps between validation scores and actual pre-
diction accuracy are likely to result from the difference in distri-
bution of orthologous GPCRs among species. As shown in Fig. 2, a
total of 1,220 human, mouse, and vertebrate CPIs include nu-
merous orthologous peptides and receptors with high SS from a
single phylum (Vertebrata), whereas invertebrate CPIs include
various species-specific peptides and GPCRs with low SS from a
wide range of phyla (e.g., Nematoda, Arthropoda, and Mollusca)
regardless of the small number (132 invertebrate CPIs). These
features of CPIs are thought to cause the overestimation of the
prediction performance by the 5-CV (SI Appendix, Fig. S6) and
leave-humans-, mice-, and vertebrates-out methods (Fig. 3A
and SI Appendix, Fig. S6).
Also of interest is that self-training using experimentally vali-
dated data (CPIs) (Fig. 4) facilitated the identification of additional
Fig. 6. Demonstration that Ci-NTLP-2-R, Ci-LF-Rs, and Ci-YFV-Rs are not evolutionarily related to any known neuropeptide GPCRs using gene trees of (A) Ci-
GALP-R, (B) Ci-NTLP-2-R, (C) Ci-LF-Rs, and (D) Ci-YFV-Rs. Phylogenic trees of ligand-identified Ciona GPCRs were constructed using the ML and NJ methods (SI
Appendix, Fig. S5 A–D, 612 sites, 450 sites, 492 sites, and 394 sites, respectively) and resultant topologies were confirmed by estimating ML trees based solely
on TM domains. Each schematic of gene trees was constructed based on the three molecular phylogenetic trees using ORTHOSCOPE 1.0.1 (58). The
monophyly-supported and -unsupported gene clades were indicated by closed triangles and open triangles, respectively. Clade names indicate inferred
functions of ancestral genes based on clade members with experimental data. The number at each branch node represents the percentage given by 100×
bootstrap replicates (ML/NJ). Ciona GPCRs characterized herein are shown in red.
Fig. 7. Gene expression profiles for Ciona neuropeptide GPCRs. Relative expression of the Ciona neuropeptide receptors to Ciona GAPDH in the indicated
tissues was confirmed by real-time PCR. Data are shown as the means of three independent experiments ± SE.
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peptide–GPCR pairs (Fig. 8), and some negative CPIs were also
generated (Fig. 5). These results provide evidence that validated
data feedback to the PD-incorporated SVM improves the pre-
diction accuracy and then verifies an unprecedented mode of li-
gand–GPCR interaction; in brief, the SVM has become more
“intelligent” by acquiring new knowledge. Novel GPCRs have also
been found in other species using next-generation sequencer-based
genome or transcriptome analyses (51, 52), whereas the cognate
ligands of most of such GPCRs have yet to be identified. In this
context, the present study indicates that our PD-incorporated SVM
(Fig. 8) can identify numerous peptide–GPCR pairs in various
organisms via self-training, leading to the elucidation of molecular
mechanisms underlying peptide–GPCR recognition and net evo-
lutionary processes of peptide–GPCR interactions. Overall, these
findings highlight the current prediction ability of the PD-
incorporated SVM using limited amounts of CPI data and in-
dicate the potential for further prediction system development for
novel human peptide–GPCR pairs, including artificial peptidic
drug candidates.
In conclusion, we have efficiently and systematically eluci-
dated multiple neuropeptide–GPCR pairs in a phylogenetically
critical invertebrate chordate, C. intestinalis Type A, using a com-
bination of machine learning and experimental validation. This
study not only contributes to the investigation of molecular mech-
anisms for various nervous, neuroendocrine, and endocrine systems
of Ciona, but also sheds light on the versatility of PD-incorporated
SVM in the identification of multiple peptide–receptor pairs.
Materials and Methods
CPI Data. CPI pairs with peptide ligands were collected from the IUPHAR
Database (53) and UniProtKB knowledge base (54). From these databases,
we utilized 261, 183, 169, 1, 13, and 10 CPI pairs for humans, mice, rats,
opossums, zebrafish, and chickens, respectively. The information about the
GPCR and peptide sequences was obtained from the UniProtKB (54). Addi-
tionally, we collected data for noninteraction pairs and invertebrate pep-
tide–GPCR interaction pairs from the literature. All of the collected
interactions and references are listed in Dataset S1. The 531 human inter-
actions (rows 2–532 in Dataset S1), 310 mouse interactions (rows 533–842 in
Dataset S1), 379 vertebrate interactions (rows 843–1,241 in Dataset S1), and
132 invertebrate interactions (rows 1,242–1,353 in Dataset S1) were used for
training datasets as positive pairs. To generate the same number of negative
pairs, we collected the reported noninteraction pairs and generated the
randomly selected negative pairs as previously reported (21, 29). A total of
3 reported noninteraction pairs (rows 1,354–1,356 in Dataset S1) and
528 randomly selected negative pairs for humans, 310 randomly selected
negative pairs for mice, 7 reported noninteraction pairs (rows 1,357–1,363 in
Dataset S1) and 372 randomly selected negative pairs for vertebrates, and
82 reported noninteraction pairs (rows 1,364–1,445 in Dataset S1) and
50 randomly selected negative pairs for invertebrates were used for
training datasets.
Peptide Kernels.We constructed the PDs with regular expression-based high-
resolution representations, which encode the existence or absence of regular
expression-represented 5-aa motifs. The descriptors were calculated in three
steps (Fig. 1A). First, we collected the 51 regular expression elements to
match amino acids, which consist of 21-bit representations of PROFEAT (32),
3 repeats, N-terminus and C-terminus marks of peptide sequences, and
25 single residues (SI Appendix, Table S2). For example, the regular expres-
sion element of [KR] (13th element of SI Appendix, Table S2) matches a
single residue of lysine or arginine. In the second step, all of the permuta-
tions and combinations of 5 of these 51 regular expression elements were
generated. For example, pHW[GASDT]Y matches the peptide sequences
possessing pyroglutamic acid, followed by histidine; followed by glycine,
alanine, threonine, aspartic acid, or serine; and followed by tyrosine. The
expression ^N.Y{1,5} matches the peptide sequences possessing asparagine
at the N terminus, followed by any amino acid, and followed by one- to five-
length repetitions of tyrosine. Third, the peptide sequences were encoded
with bit (0, 1) vectors, which represent each regular expression match (= 1) or
nonmatch (= 0). Then, to unify redundant regular expressions, if there was a
pair of regular expressions appearing in the same compound set, the regular
expression showing the narrower range was removed. The inner products of
these bit vector pairs were calculated as the kernels for each peptide pair.
We also calculated the mismatch descriptor to compare with our proposed
regular expression-based descriptors, which is a class of string kernels that
compares sequence strings representing k-mer subsequences. The mismatch
kernel allows for mutations between the subsequences. Specifically, the
mismatch kernel is calculated based on shared occurrences of (k-m)-patterns
in the data, where the (k-m)-patterns consist of all k-length subsequences
that differ from a fixed k-length sequence pattern by at mostmmismatches.
Fig. 8. PD-incorporated SVM cycle: the prediction-experimental validation-data feedback is a powerful procedure for deorphanization of GPCRs for novel
neuropeptides. The original prediction model was constructed by learning positive data (red dots) and negative data (blue dots) for known neuropeptide–
GPCR pairs, followed by cell-based signaling assays of each predicted pair; predicted GPCR–peptide pairs are green dots, positive matches are yellow dots, and
false positives are purple dots. The feedback of experimentally validated neuropeptide–GPCR pairs updated the prediction model, which enabled the pre-
diction of more positive GPCR–peptide pairs. This improved prediction model indicated that repeated prediction-experimental validation-feedback cycles
make the PD-incorporated SVM more “intelligent” and improve the prediction performance.
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The inner products of bit vector pairs were calculated as the mismatch
kernels for each peptide pair.
GPCR Kernels. TM z-scale descriptors were employed for representations of
GPCRs, as previously described (21). Briefly, seven TM sequences were di-
rectly substituted with the z-scale vectors that represent five leading principal
components obtained from 26 measured and computed physicochemical
properties of amino acids. The 935-dimensional descriptors were generated
by concatenating 5D vectors (z1−z5) for each of the 187 residues of TMs in
GPCRs. The inner products of GPCR descriptor pairs were calculated as GPCR
kernels for each GPCR pair.
Similarity Scores. The SSs of the GPCRs and peptides were defined as Tanimoto
coefficients (33) of their top 1% most similar GPCRs and peptides, respectively,
as described in our previous study (21). For calculation of Tanimoto coefficients,
we utilized TM z-scale descriptors and regular expression-based descriptors for
GPCRs and peptides, respectively.
CPI Pair Kernels and SVM Prediction. We utilized kernel methods to in-
corporate CPI data into SVMs (55) for constructing prediction models, as
previously described (21). Here, kernels for CPI pairs were represented as the
products of linear kernels for PDs and GPCR descriptors. Parameters of the
SVM regularization were optimized using a grid search. All of the training
and test CPIs are included in Dataset S1.
Performance Evaluation. The prediction performance of our proposed model
was evaluated using LOSO internal validation, as previously reported (21, 26,
28). In the present LOSO validation, the CPIs and noninteraction pairs par-
titioned into human data, mouse data, vertebrate data, and invertebrate
data were predicted using models containing the other CPIs and non-
interaction pairs. For example, for the leave-humans-out validation, mouse,
vertebrate, and invertebrate CPIs (rows 533–1,353 in Dataset S1) and non-
interaction pairs were used for SVM training, and prediction performances
(ACC and AUC) were calculated using the prediction results for human CPIs
and noninteraction pairs. The performance of the internal validation was
measured by ACC = (TP+TN)/(TP+TN+FP+FN), where TP, TN, FP, and FN de-
note the numbers of true positives, true negatives, false positives, and false
negatives, respectively. To further confirm the prediction performance of
CPIs using LOSO analysis, we also measured the performance of internal
validation using the AUC (56), which is an index independent of the decision
threshold of the prediction model and class probability distributions of
predicted data. SEMs of ACCs and AUCs were estimated by five repeated
experiments with independently generated negative data. Differences be-
tween AUCs and ACCs were evaluated using a Student’s t test as appropri-
ate, with P < 0.05 considered as significant.
Peptide Synthesis. The peptide sequences we utilized are listed in SI Ap-
pendix, Table S1. All peptides were synthesized using an ABI 430A solid-
phase peptide synthesizer (Applied Biosystems) and the Fast Moc method,
according to the manufacturer’s instruction.
Gαq16-Fused C. intestinalis GPCRs. Each GPCR ID in the Ghost database (35)
was indicated by abbreviated IDs without splicing variant information. The
full-length IDs are listed in SI Appendix, Table S4. C. intestinalis putative full-
length GPCRs—KH.C3.660, KH.C9.683, KH.C4.122, KH.C2.1132, KH.C2.1037, KH.
C2.878, KH.C2.212, KH.C1.745, and KH.C8.781—were cloned from the central
nervous system and were C-terminally fused with human Gαq16 protein, which
was coupled with GPCRs and triggered intracellular calcium mobilization upon
binding of a specific ligand (57). The human Gαq16 ORF clone (OriGene) was
amplified (SI Appendix, Table S7) and ligated into the XbaI site of a pFastbacI
plasmid (Invitrogen). Then, KH.C3.660, KH.C9.683, KH.C4.122, KH.C2.1132, KH.
C2.1037, KH.C2.878, KH.C2.212, KH.C1.745, and KH.C8.781 were cloned into the
NotI/XbaI site of the Gαq16-ligated pFastbacI plasmids, respectively. Trans-
formation of competent cells with the Ciona GPCR-Gαq16-pFastbacI plasmid and
the resulting bacmid isolation was performed according to the manufacturer’s
instructions for the Bac-to-Bac system (Thermo Fisher Scientific).
Calcium Accumulation Assay. Sf9 cells (Thermo Fisher Scientific) were grown in
Sf900 II (Thermo Fisher Scientific) containing 10% FBS (Sigma) at 28°C. Ciona
GPCR-Gαq16-recombinant baculoviruses were generated in Sf9 cells trans-
fected with the above bacmids using Cellfectin II, titrated, isolated, and
transiently transfected into Sf9 cells using the Bac-to-Bac system according
to the manufacturer’s instruction (Thermo Fisher Scientific). Forty-eight
hours after transfection, Sf9 cells were loaded for 30 min with 2.5 μM of
Fluo-8 AM (AAT Bioquest) diluted in loading buffer [HBSS supplemented
with 1.25 mM of probenecid and 0.04% (wt/vol) of pluronic F-127]. Each
Ciona GPCR-fused human Gαq16 expression at cell membrane was confirmed
by immunostaining using the anti-Gαq16 antibody (Ori Gene TA318890). Var-
ious concentrations of peptides were administrated to Sf9 cells in a FlexStation
II-automated apparatus (Molecular Devices). Real-time fluorescent kinetics for
Fluo-8 were observed at excitation/emission wavelengths of 490/514 nm. The
calcium accumulation data were analyzed using Prism v6 (GraphPad) to fit to
a sigmoidal concentration-response curve, and the means ± SEMs of EC50
were calculated.
Real-Time PCR. Total RNA (2 μg) extracted from various tissues of Ciona was
reverse-transcribed using SuperScript III (Invitrogen) and oligo (dT)
20 primer. Real-time PCR was performed using the CFX96 Real-time System
and SsoAdvanced Universal SYBR Green Supermix (Bio-Rad Laboratories).
Total volume of reaction mixtures was 20 μL, consisting of 100-ng template
cDNA, each 500-nM primer, and 10 μL SYBR Green Master Mix solution. PCR
was performed for initial steps at 95 °C for 30 s, followed by 44 cycles at
95 °C for 15 s and at 60 °C for 30 min. A melting-curve analysis was per-
formed to confirm the absence of primer dimers. Ct values for GAPDH and
identified GPCR genes were calculated according to the manufacturer’s in-
struction. The mean ± SEM of GAPDH-normalized ΔCt values were estimated
from three replicates. Sequences of the primers used for the real-time PCR
are listed in SI Appendix, Table S8.
Molecular Phylogenetic Analysis for Ciona GPCRs. GPCR sequences similar to
the identified Ciona GPCR sequences were extracted by ORTHOSCOPE 1.0.1
(58). To implement a BLAST search in ORTHOSCOPE, coding sequences from
Ci-GALP-R, Ci-NTP-2-R, Ci-LF-1-R, and Ci-YFL-1-R were used as queries against
gene models of vertebrates (Homo sapiens and Gallus gallus), urochordates
(C. intestinalis, Ciona savignyi, B. schlosseri, and O. dioica), cephalochordates
(Branchiostoma floridae and Branchiostoma belcheri), echinoderms (Acanthaster
planci and Strongylocentrotus purpuratus), hemichordates (Ptychodera flava and
Saccoglossus kowalevskii), and protostomes (D. melanogaster, C. elegans, and
Lingula anatina). The BLAST hit sequences were screened using an E-value cut-off
of <10−3, and the top five hits were used for the subsequent phylogenetic
analyses. The protein sequences retrieved by the ORTHOSCOPE analyses
were aligned using MAFFT (59). Multiple sequence alignments were trim-
med by removing poorly aligned regions using TRIMAL 1.2 (60) with the
option “gappyout.” Corresponding coding sequences were forced onto the
amino acid alignment using PAL2NAL (61) to generate nucleotide alignments
for following analyses.
Gene phylogenetic trees were estimated using ML and NJ methods with
the first and second codon positions and bootstrap analyses of genes
encoding full-length sequences (for NJ and ML analyses) and TM domains
(for ML analysis) of GPCRs based upon 100 replicates. Codon-partitioned
ML analyses were performed with RAxML 8.2.12 (62), which invokes a
rapid bootstrap analysis and searches for the best-scoring ML tree with
the general time-reversible with gamma (GTRGAMMA) (63, 64) model. NJ
analyses were conducted using the software package Ape in R using the
TN93 model (65) with γ-distributed rate heterogeneity (64). The sequences
for ligand-identified GPCRs in this paper are presented in Dataset S3. The
molecular phylogenetic trees of full-length sequences (for NJ and ML
analyses) and TM domains (for ML analysis) of GPCRs were constructed
using the MEGA software (v7) (66). Each schematic of gene trees was
constructed by focusing on gene clades consistently supported by the
three molecular phylogenetic trees (SI Appendix, Fig. S5) using the
ORTHOSCOPE, as previously reported (58).
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